Literature DB >> 18310505

A developmental model of sarcomagenesis defines a differentiation-based classification for liposarcomas.

Igor Matushansky1, Eva Hernando, Nicholas D Socci, Tulio Matos, Joslyn Mills, Mark A Edgar, Gary K Schwartz, Samuel Singer, Carlos Cordon-Cardo, Robert G Maki.   

Abstract

The importance of adult stem cells in the development of neoplastic diseases is becoming increasingly well appreciated. We hypothesized that sarcomas of soft tissue could be categorized by their developmental/differentiation status from stem cell to mature tissue, similar to the hematological malignancies. We conducted gene expression analyses during in vitro differentiation of human mesenchymal stem cells into adipose tissue, as a representative mature connective tissue, and identified genes whose expression changed significantly during adipogenesis. Gene clustering and distance correlation analysis allowed the assignment of a unique time point during adipogenesis that strongly correlates to each of the four major liposarcoma subtypes. Using a novel gene expression strategy, in which liposarcomas are compared to their corresponding adipocytic maturing cells, we identified a group of genes overexpressed in liposarcomas that indicate the stage of differentiation arrest, ie, sharing a similar expression profile to adipocytic cells at a corresponding stage of differentiation, and a distinct set of genes overexpressed in liposarcomas that are not found in the corresponding stage of differentiation. We propose that the latter set is enriched for candidate transformation-associated genes. Our results indicate that a degree of developmental maturity can be quantitatively assigned to solid tumors, supporting the notion that transformation of a solid tumor stem cell can occur at distinct stages of maturation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18310505      PMCID: PMC2276417          DOI: 10.2353/ajpath.2008.070284

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  26 in total

Review 1.  Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: liposarcoma.

Authors:  Avery A Sandberg
Journal:  Cancer Genet Cytogenet       Date:  2004-11

Review 2.  Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions.

Authors:  A Orfao; G Schmitz; B Brando; A Ruiz-Arguelles; G Basso; R Braylan; G Rothe; F Lacombe; F Lanza; S Papa; P Lucio; J F San Miguel
Journal:  Clin Chem       Date:  1999-10       Impact factor: 8.327

3.  Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma.

Authors:  G D Demetri; C D Fletcher; E Mueller; P Sarraf; R Naujoks; N Campbell; B M Spiegelman; S Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

4.  Clear cell sarcoma of tendons and aponeuroses: case presentation with special reference to immunohistochemical findings.

Authors:  G Mechtersheimer; W Tilgen; E Klar; P Möller
Journal:  Hum Pathol       Date:  1989-09       Impact factor: 3.466

5.  Classification of human liposarcoma and lipoma using ex vivo proton NMR spectroscopy.

Authors:  K Millis; P Weybright; N Campbell; J A Fletcher; C D Fletcher; D G Cory; S Singer
Journal:  Magn Reson Med       Date:  1999-02       Impact factor: 4.668

6.  Molecular abnormalities in liposarcoma: role of MDM2 and CDK4-containing amplicons at 12q13-22.

Authors:  S Pilotti; G Della Torre; C Lavarino; G Sozzi; F Minoletti; B Vergani; A Azzarelli; F Rilke; M A Pierotti
Journal:  J Pathol       Date:  1998-06       Impact factor: 7.996

7.  Human translocation liposarcoma-CCAAT/enhancer binding protein (C/EBP) homologous protein (TLS-CHOP) oncoprotein prevents adipocyte differentiation by directly interfering with C/EBPbeta function.

Authors:  G Adelmant; J D Gilbert; S O Freytag
Journal:  J Biol Chem       Date:  1998-06-19       Impact factor: 5.157

8.  Phase IV trial of daily oral etoposide in the treatment of advanced soft-tissue sarcoma.

Authors:  J D Licht; R Mazanet; P J Loehrer; R Gonin; K H Antman
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

9.  Stem cell expression of the AML1/ETO fusion protein induces a myeloproliferative disorder in mice.

Authors:  Timothy S Fenske; Gina Pengue; Vikram Mathews; Piia T Hanson; Sarah E Hamm; Noor Riaz; Timothy A Graubert
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-11       Impact factor: 11.205

10.  Correlation of lipid content and composition with liposarcoma histology and grade.

Authors:  S Singer; K Millis; K Souza; C Fletcher
Journal:  Ann Surg Oncol       Date:  1997 Oct-Nov       Impact factor: 5.344

View more
  41 in total

Review 1.  Modeling sarcomagenesis using multipotent mesenchymal stem cells.

Authors:  Rene Rodriguez; Ruth Rubio; Pablo Menendez
Journal:  Cell Res       Date:  2011-09-20       Impact factor: 25.617

2.  PAX7-FKHR fusion gene inhibits myogenic differentiation via NF-kappaB upregulation.

Authors:  Elizabeth Charytonowicz; Igor Matushansky; Josep Domingo Doménech; Mireia Castillo-Martín; Marc Ladanyi; Carlos Cordon-Cardo; Mel Ziman
Journal:  Clin Transl Oncol       Date:  2012-03       Impact factor: 3.405

3.  Cyclin-dependent kinase 11 (CDK11) is crucial in the growth of liposarcoma cells.

Authors:  Bin Jia; Edwin Choy; Gregory Cote; David Harmon; Shunan Ye; Quancheng Kan; Henry Mankin; Francis Hornicek; Zhenfeng Duan
Journal:  Cancer Lett       Date:  2013-09-02       Impact factor: 8.679

4.  Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers.

Authors:  Giulia Grisendi; Rita Bussolari; Elena Veronesi; Serena Piccinno; Jorge S Burns; Giorgio De Santis; Pietro Loschi; Marco Pignatti; Fabrizio Di Benedetto; Roberto Ballarin; Carmela Di Gregorio; Valentina Guarneri; Lino Piccinini; Edwin M Horwitz; Paolo Paolucci; Pierfranco Conte; Massimo Dominici
Journal:  Am J Cancer Res       Date:  2011-05-28       Impact factor: 6.166

5.  A model to explain specific cellular communications and cellular harmony:- a hypothesis of coupled cells and interactive coupling molecules.

Authors:  Cyril J Craven
Journal:  Theor Biol Med Model       Date:  2014-09-14       Impact factor: 2.432

Review 6.  Soft tissue sarcomas with complex genomic profiles.

Authors:  Louis Guillou; Alain Aurias
Journal:  Virchows Arch       Date:  2010-02       Impact factor: 4.064

7.  Targeting sarcoma tumor-initiating cells through differentiation therapy.

Authors:  Dan Han; Veronica Rodriguez-Bravo; Elizabeth Charytonowicz; Elizabeth Demicco; Josep Domingo-Domenech; Robert G Maki; Carlos Cordon-Cardo
Journal:  Stem Cell Res       Date:  2017-04-13       Impact factor: 2.020

8.  Sustained activation of notch signaling maintains tumor-initiating cells in a murine model of liposarcoma.

Authors:  Pei-Chieh Tien; Menchus Quan; Shihuan Kuang
Journal:  Cancer Lett       Date:  2020-08-28       Impact factor: 8.679

9.  A differentiation-based phylogeny of cancer subtypes.

Authors:  Markus Riester; Camille Stephan-Otto Attolini; Robert J Downey; Samuel Singer; Franziska Michor
Journal:  PLoS Comput Biol       Date:  2010-05-06       Impact factor: 4.475

10.  Heterogeneity and immunophenotypic plasticity of malignant cells in human liposarcomas.

Authors:  Yan Zhang; Eric D Young; Katelynn Bill; Roman Belousov; Tingsheng Peng; Alexander J Lazar; Raphael E Pollock; Paul J Simmons; Dina Lev; Mikhail G Kolonin
Journal:  Stem Cell Res       Date:  2013-05-12       Impact factor: 2.020

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.